Cat.#: BBM-3C-037
Description | Soluble Collagen TypeⅠ from Ace Therapeutics is purified fromBovine achilles tendon by the Birkedal-Hansen method. |
Source | Bovine achilles tendon |
Size | 1 mg/vial |
Form | White to off-white lyophilized |
Sterility | Passed sterility test for bacteria and fungi. |
Concentration | 10 mg/mL |
Storage | 2-8℃ for 8 years. |
Shipping | Dry ice |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Description | Price |
---|---|---|---|
BBM-3C-068 | Cultrex Mouse Collagen IV |
Cultrex Mouse Collagen IV from Ace Therapeutics is a stromal extracellular matrix protein purified from a murine engelbreth-holm-swarm (EHS) tumor. This product can promote cell adhesion in cell and tissue cultures as well as be used as a hydrogel or thin coating for tissue culture vessels.
|
inquiry |
BBM-3C-022 | Mouse Collagen Type I and III, 5 mg |
Mouse Collagen Type I and III, 5 mg from Ace Therapeutics is purified from rom tail tendons of the mouse.
Type I collagen is the most abundant collagen and is found in connective tissues including tendons, ligaments, dermis, and blood vessels. Type III collagen is the second most abundant collagen in tissues and is found most commonly in tissues exhibiting elastic properties such as skin, lungs, intestinal walls, and walls of blood vessels, which resembles other fibrillar collagens in structure and function.
|
inquiry |
BBM-3C-062 | Collagens Type Ⅳ |
Collagens Type IV is derived from bovine tissue treated with pepsin. This product does not gel and needs to be mixed with collagen type I-A.
|
inquiry |
BBM-3C-052 | Human Collagen Type IV |
Collagen Type IV is a common component of the basement membrane. Human Collagen Type IV from Ace Therapeutics is a purified collagen derived from adult human placenta tissue, and the product can be used to regulate cell growth, differentiation, and tissue formation.
|
inquiry |
BBM-3C-047 | Rat Tail Collagen Type I, Sterile, Filtered |
Rat Tail Collagen Type I, Sterile, Filtered, from Ace Therapeutics is a purified collagen derived from the rat tail. The Product can be used as a thin layer on tissue culture surfaces to enhance cell adhesion and proliferation, or as a glue layer to promote the expression of specific cell morphology and function. The product is typically used to culture endothelial cells, stem cells, muscle cells, and a variety of other cells.
|
inquiry |
BBM-3C-033 | Human Collagen Type III, 0.1 mg |
Human Collagen Type III, 0.1 mg from Ace Therapeutics is purified from human cartilage.
Type III collagen is the second most abundant collagen in tissues and is found most commonly in tissues exhibiting elastic properties such as skin, lungs, intestinal walls, and walls of blood vessels, which resembles other fibrillar collagens in structure and function. Type III collagen together with type I collagen are the main constituents of the interstitial matrix.
|
inquiry |
BBM-3C-044 | Collagen, Type I Solution from Rat Tail |
Collagen, Type I Solution from Rat Tail from Ace Therapeutics is derived from rat tail, which used in tissue engineering especially in the generation of 3-D scaffolds based gels.
|
inquiry |
BBM-3C-056 | Porcine Gelatine |
Porcine Gelatine from Ace Therapeutics is a purified gelatin matrix from porcine tissue. The product can enhance the adsorption of various normal cells and transfected cells.
|
inquiry |
BBM-3C-045 | Collagen from Human Placenta |
Collagen from Human Placenta is supplied as a 0.5 M acetic acid solution. It can be used to coat tissue culture surfaces to promote cell attachment
|
inquiry |
BBM-3C-043 | Collagen from Human Placenta |
Collagen from Human Placenta is used to induce differentiation of endothelial cells and rat pluripotent cells. This product is a lyophilized powder that can be reconstituted at 1 mg/mL in sterile 0.5 M acetic acid, PBS, or water.
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.